# Ambagon Therapeutics: Research, Eindhoven, Netherlands

> Ambagon Therapeutics: Ambagon Therapeutics is a biotechnology company focused on developing innovative therapies for challenging protein targets...

Source: https://millionrounds.com/startup/ambagon-therapeutics (Millionrounds; every figure on the page links to its filing or article)

Netherlands · [Research startup](https://millionrounds.com/companies)

# Ambagon Therapeutics

Ambagon Therapeutics is a biotechnology company focused on developing innovative therapies for challenging protein targets, particularly intrinsically disordered proteins.

Funding reported Last round: Undisclosed round

Research Eindhoven, Netherlands

Company summary

- **Founded:** 2020 6 years old
- **Team:** 15 11 to 50 people
- **Funding reported:** 148M as listed, currency not stated
- **Last round:** Undisclosed round May 2022

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Ambagon Therapeutics has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Ambagon Therapeutics

Ambagon Therapeutics is a biotechnology company focused on developing innovative therapies for challenging protein targets, particularly intrinsically disordered proteins.

Founded in 2020 by Christian Ottmann, Luc Brunsveld, and Michelle Arkin, the company operates from its headquarters in San Carlos, California, and has a significant presence in Eindhoven, Netherlands. With a team of approximately 18 employees, Ambagon has raised over $103 million in funding, including an $85 million Series A round in January 2022. The company’s primary technology is its Molecular Glue Platform, which aims to stabilize protein interactions and modulate protein functions. Ambagon is currently in the discovery phase, working on five programs with a focus on oncology, particularly breast cancer, while also addressing other therapeutic areas such as metabolic disorders and neurodegenerative diseases. The company is expected to announce a development candidate in 2023 and aims to enter clinical trials in 2024.

## What company datasets say Ambagon Therapeutics raised

Funding, as reported

Reported in all **148M** in the source's currency

Rounds **3**

Last round **Undisclosed round**

Last round size **5M**

Last round date **May 2022**

Investors listed **8**

## The company, in detail

What they build

Known for

health care oncology proteome expansion biotechnology research target stabilization structure-based drug design protein stabilization healthcare modular platform biomolecular complexes medical research drugging disordered proteins high-throughput screening molecular glues for neurodegeneration pharmaceuticals pharmacodynamics

Built with from their website

Yoast SEO Google Tag Manager Priority Hints Google Font API WordPress.org Microsoft Exchange Nginx Atlassian PWA Microsoft 365

+8 more

WOW Font Awesome MySQL PrimeNG Outlook Zoom Meetings Microsoft 365 Apps & Services PHP

- **Sector:** Research
- **Industry code:** NAICS 541714, SIC 2834
- **Region:** North Brabant
- **Revenue:** 3.1M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/ambagon-therapeutics)

## Research in Netherlands

Startups like it

- [**Citryll** Oss · founded 2015 *Raised*](https://millionrounds.com/company/citryll)
- [**Leyden Labs** Leiden · founded 2020 *Raised*](https://millionrounds.com/company/leyden-labs)
- [**NorthSea Therapeutics** Amsterdam · founded 2017 *Raised*](https://millionrounds.com/company/northsea-therapeutics)
- [**Synerkine Pharma** Leiden · founded 2018 *Raised*](https://millionrounds.com/company/synerkine-pharma)
- [**ENPICOM** 's-Hertogenbosch · founded 2015 *Raised*](https://millionrounds.com/company/enpicom)
- [**PHOSPHOENIX** Amsterdam · founded 2019 *Raised*](https://millionrounds.com/company/phosphoenix)
- [**AZAFAROS B.V.** Naarden · founded 2018](https://millionrounds.com/startup/azafaros-b-v)
- [**VectorY** Amsterdam · founded 2020](https://millionrounds.com/startup/vectory)

## Is this your company?

Add your raise, your deck and your story, and put Ambagon Therapeutics in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)